Cargando…
Population-Wide Emergence of Antiviral Resistance during Pandemic Influenza
BACKGROUND: The emergence of neuraminidase inhibitor resistance has raised concerns about the prudent use of antiviral drugs in response to the next influenza pandemic. While resistant strains may initially emerge with compromised viral fitness, mutations that largely compensate for this impaired fi...
Autores principales: | Moghadas, Seyed M., Bowman, Christopher S., Röst, Gergely, Wu, Jianhong |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2266801/ https://www.ncbi.nlm.nih.gov/pubmed/18350174 http://dx.doi.org/10.1371/journal.pone.0001839 |
Ejemplares similares
-
A Delay Differential Model for Pandemic Influenza with Antiviral Treatment
por: Alexander, Murray E., et al.
Publicado: (2007) -
Antiviral resistance during pandemic influenza: implications for stockpiling and drug use
por: Arino, Julien, et al.
Publicado: (2009) -
Post-exposure prophylaxis during pandemic outbreaks
por: Moghadas, Seyed M, et al.
Publicado: (2009) -
Population dynamics of epidemic and endemic states of drug-resistance emergence in infectious diseases
por: Knipl, Diána, et al.
Publicado: (2017) -
Antiviral Strategies for Emerging Influenza Viruses in Remote Communities
por: Laskowski, Marek, et al.
Publicado: (2014)